Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03174925
Other study ID # IRB-23634
Secondary ID NCI-2017-00841EN
Status Completed
Phase N/A
First received
Last updated
Start date January 24, 2014
Est. completion date February 13, 2019

Study information

Verified date June 2021
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial studies how well ultrasound elastography works in assessing the cancer status of potentially malignant thyroid nodules.


Description:

PRIMARY OBJECTIVES: Determine the utility of ultrasound elastography in evaluation of thyroid nodules being evaluated for the presence of cancer. Elastography measures the passages of ultrasound shear waves through tissue to gauge the stiffness and compressibility of the tissue, collectively "tissue stiffness," and may be a better way to image thyroid nodules. Tissue stiffness is a physiological parameter that is being evaluated for differences between non-cancerous (benign) and cancerous thyroid nodules. Participants will undergo elastography over the 10 minutes prior to either fine needle aspiration of a biopsy specimen or surgical resection of the thyroid nodule. Tissue specimens from the biopsy specimen or surgical resection will be assessed pathologically to determine actual cancer status.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date February 13, 2019
Est. primary completion date February 13, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Presence of a thyroid nodule that is amenable to ultrasound guided fine needle aspiration Exclusion Criteria: - Patients who are unable to lie supine for a biopsy - Pregnant patients

Study Design


Intervention

Device:
Siemens Acuson S3000 ultrasound system
Shear Wave Elastography

Locations

Country Name City State
United States Stanford University, School of Medicine Palo Alto California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stiffness of Thyroid Nodules as Measured by Elastography Potentially cancerous thyroid nodules will be assessed elastographically, and cancer status will be determined from a fine needle aspiration biopsy results or the surgically excised nodule. The outcome will be reported as median tissue stiffness with standard deviation for nodules that were determined non-cancerous (benign), cancerous, or indeterminate. 1 week
See also
  Status Clinical Trial Phase
Withdrawn NCT03676647 - Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
Suspended NCT04742608 - Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Recruiting NCT05003856 - Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule N/A